Silk Road Medical Inc

NASDAQ:SILKUnited States

Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.

Contact Information

Headquarters

1213 Innsbruck DrSUNNYVALE, CA, United States 94089-1317

Phone

650-566-9060

Fax

302-655-5049

Executives

Independent Chairman of the Board

Jack Lasersohn

Chief Executive Officer, Director

Charles McKhann

Chief Financial Officer, Chief Operating Officer

Lucas Buchanan

Executive Vice President, Chief Legal Officer, Secretary

Kevin Klemz

Executive Vice President - Regulatory Affairs, Clinical Affairs and Quality Assurance

Richard Ruedy